Nivolumab shows promise in advanced cutaneous squamous cell carcinoma
Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...
top of page
it's where dermatology lives
John Evans
Oct 28, 20222 min read
Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery
Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...
John Evans
Jan 7, 20222 min read
Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma
Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...
Featured Posts
bottom of page